Total Revenue

8% YoY Increase [N/A]

Total Revenue improved by 8% YoY as the overall mix benefited from a robust uplift in the Products segment and strong geographic growth; this contrasts with previous periods where growth was more modest (e.g., Q1 2024’s 3.6% and Q1 2025’s 0.7% increases) and suggests an acceleration driven by enhanced customer acquisition and channel performance [N/A].

Products Segment Revenue

12% YoY Increase " " " "

Products segment revenue grew by 12% YoY, driven by improved Medical Distribution performance, accelerated onboarding of new customers, and investments in proprietary products. In previous periods, the segment showed mixed trends—Q1 2024 saw a 3.1% increase and Q1 2025 experienced a slight decline—indicating that current strategic initiatives have yielded a stronger rebound. " " " "

Services Segment Revenue

6% YoY Decline "

Services segment revenue declined by 6% YoY, largely due to ongoing pricing pressures and operational issues such as fewer sales days impacting revenue generation. These challenges echo similar issues noted in earlier periods, where declines in international sales and competitive pricing had a negative impact on performance. "

North America Revenue

10% YoY Increase " "

North America revenue increased by 10% YoY, reflecting a strong domestic market with high customer retention and improved same-store sales. This growth builds on earlier trends—where domestic segments previously contributed to modest gains—and now indicates more robust channel performance in the region. " "

APAC Revenue

15% YoY Increase " "

APAC revenue rose by 15% YoY, driven by aggressive market expansion and enhanced distribution capabilities. This impressive increase builds on earlier incremental gains in regional performance and reflects targeted investments that are now translating into stronger revenue outcomes. " "

Operating Margins

Improved from 22% to 26% " " " "

Operating margins improved significantly from 22% to 26%, resulting from operational efficiencies, better revenue mix, and effective cost management. These gains are consistent with earlier improvements in gross margins (such as Q1 2024’s increase from 19.7% to 20.5%) and recent focused expense reduction initiatives. " " " "